Astrana Health (NASDAQ:ASTH – Get Free Report) had its price target reduced by equities researchers at Stifel Nicolaus from $50.00 to $45.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ target price points to a potential upside of 27.33% from the stock’s current price.
A number of other analysts have also issued reports on the company. Truist Financial raised their price target on Astrana Health from $41.00 to $44.00 and gave the stock a “hold” rating in a research note on Friday, March 1st. Jefferies Financial Group initiated coverage on shares of Astrana Health in a research report on Monday, February 26th. They issued a “buy” rating and a $50.00 target price on the stock.
Get Our Latest Research Report on Astrana Health
Astrana Health Stock Down 6.8 %
Astrana Health (NASDAQ:ASTH – Get Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.31 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.01). Astrana Health had a net margin of 4.49% and a return on equity of 11.52%. The business had revenue of $404.36 million during the quarter, compared to analyst estimates of $413.84 million. During the same quarter last year, the firm posted $0.42 earnings per share. The company’s revenue was up 19.9% on a year-over-year basis. As a group, equities analysts forecast that Astrana Health will post 1.65 EPS for the current year.
About Astrana Health
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Articles
- Five stocks we like better than Astrana Health
- Market Cap Calculator: How to Calculate Market Cap
- How to Read an Earnings Report | Step by Step Guide with Tips
- What Investors Need to Know About Upcoming IPOs
- Datadog: In the Doghouse or Pullback to the Buyzone?
- Golden Cross Stocks: Pattern, Examples and Charts
- Celsius Stock’s Post-Earnings Morning Dip, Better than Coffee
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.